Rabeprazole Sodium
CAS 117976-90-6 20 FDA-DMF suppliersSmall Molecule
Overview
Rabeprazole Sodium is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase enzyme system at the secretory surface of the gastric parietal cell. It is widely used in the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers and Zollinger-Ellison syndrome.
API suppliers (21)
Suppliers of Rabeprazole Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF
- SYN-TECH CHEM AND PHARM CO LTD1 active DMF
- Macleods Pharmaceuticals Ltd.India1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF
- SYN-TECH CHEM AND PHARM CO LTD1 active DMF
- MOEHS IBERICA SLSpain1 active DMF
- Orchid Pharma LimitedIndia1 active DMF
- Cadila Pharmaceuticals LimitedIndia
- MYLAN LABORATORIES LTD
- Alembic Pharmaceuticals LimitedIndia
- UQUIFA MEXICO SA DE CV
- NOSCH LABS PRIVATE LTD
- Hetero Drugs LimitedIndia
- Sun Pharmaceutical Industries LimitedIndia
- SHANGHAI SINE PHARMACEUTICAL LABORATORIES CO LTD
- Cipla USA, Inc.USA
- Cadila Healthcare LimitedIndia
- SINTENOVO SA DE CV
Therapeutic areas
Gastroenterology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.